Institute for Evidence-Based Positioning in the Healthcare Sector

The rapid evolution of large language models (LLMs) and machine learning (ML) presents both significant opportunities and challenges for market access processes.
In an invited article for the Journal of Medical Economics, I explore the limitations and future potential of AI applications across the individual steps of the Pricing, Reimbursement and Market Access process (PRMA) from a German perspective and in light of the EU HTA Regulation.
Read more: https://www.tandfonline.com/doi/epdf/10.1080/13696998.2025.2488154?needAccess=true

Following a presentation at the World EPA Congress in Amsterdam, an interview with Becaris Publishing, publisher of The Evidence Base, addresses the current role of Real World Evidence (RWE) in Germany, explores the reasons behind the country’s cautious stance, and highlights specific scenarios in which real world data have already been considered — including methodological suggestions from IQWiG: https://becarispublishing.com/digital-content/blog-post/navigating-use-real-world-evidence-drug-assessment-germany-interview-eva-susanne

Vaccinations in focus: new chapter in Springer compendium

Vaccination is a central component of health care – but how are vaccination rates, legislation and economics evolving? In my new chapter ‘Vaccinations’ in the compendium Health Insurance and Care Insurance Management (Springer-Verlag), I examine the role of the STIKO, the legal framework and the challenges for the health care system. I also discuss the growing vaccine market and whether new evaluation methods will be needed to control costs in the future. The full online version can be found here: https://link.springer.com/referenceworkentry/10.1007/978-3-658-31244-2_31-1